Your browser doesn't support javascript.
loading
Probiotic bacteria: a viable adjuvant therapy for relieving symptoms of rheumatoid arthritis.
Wang, Peng; Tao, Jin-Hui; Pan, Hai-Feng.
Afiliación
  • Wang P; Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, 81 Meishan Road, Hefei, 230032, Anhui, China.
  • Tao JH; Anhui Provincial Laboratory of Population Health & Major Disease Screening and Diagnosis, Hefei, Anhui, China.
  • Pan HF; Department of Rheumatology, Anhui Provincial Hospital, Hefei, Anhui, China.
Inflammopharmacology ; 24(5): 189-196, 2016 Oct.
Article en En | MEDLINE | ID: mdl-27581587
ABSTRACT
The burgeoning use of probiotics has proliferated during the past two decades. However, the effect of probiotic administration for either the prevention or treatment of rheumatoid arthritis (RA) has been investigated in a limited number of studies. Randomized controlled clinical trials have provided evidences that specific probiotics supplementation exhibit anti-inflammatory effects, help to increase daily activities and alleviate symptoms in patients with RA. Therefore, using probiotic bacteria as an adjuvant therapy may be considered as a promising treatment option for RA. This review summarizes the available data about the therapeutic and preventive effect of probiotics in RA, together with probiotic supplement as a possible therapy in clinical treatment.
Asunto(s)
Palabras clave
Buscar en Google
Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Artritis Reumatoide / Probióticos / Lactobacillus Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Animals / Humans Idioma: En Revista: Inflammopharmacology Asunto de la revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2016 Tipo del documento: Article País de afiliación: China
Buscar en Google
Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Artritis Reumatoide / Probióticos / Lactobacillus Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Animals / Humans Idioma: En Revista: Inflammopharmacology Asunto de la revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2016 Tipo del documento: Article País de afiliación: China